Tucker LeBien, PhD

Director, Office of Discovery and Translation, Clinical and Translational Science Institute (CTSI)

Tucker LeBien

Contact Info


Office Phone 612-626-1422

Fax 612-626-2696

Mailing Address:
Office of Academic Clinical Affairs
420 Delaware Street SE
MMC 501
Minneapolis, MN 55455

Administrative Assistant Name
Lauren Bigalke

Administrative Email

Director, Office of Discovery and Translation, Clinical and Translational Science Institute (CTSI)

University of Nebraska Medical Center, Nebraska, Ph.D. (Medical Microbiology – Immunology), 1977

North Dakota State University, North Dakota , M.S. (Bacteriology), 1973

North Dakota State University, North Dakota, B.S. (Zoology), 1970


Awards & Recognition

  • Alumni Achievement Award, North Dakota State University, 2002
  • Apogee Enterprises Chair in Cancer Research, 1999 – 2015
  • Associate Editor, Blood, 1991 – 1997
  • Stohlman Memorial Award, Leukemia Society of America, 1989
  • McFadden Lectureship, Nebraska Medical Center, 1987
  • Short Term Scientific Exchange Award, Leukemia Society of America, 1986
  • Award of Excellence, Alison Eberlein Fund, Inc., 1984
  • Scholar of the Leukemia Society of America, 19984 – 1989
  • Travel Scholarships to: IV Int. Cong. Of Immunology, Paris, 1980; X. Cong. of the Int. Soc. for Experimental Hematology, Munich, 1981; V. Int. Cong. of Immunology, Kyoto, 1983; 3rd National Conference of the Leukemia Society of America, San Diego, 1987.
  • National Cancer Institute New Investigator Award, 1980 - 1982

Professional Associations

American Association of Immunologists
American Association for Cancer Research
American Society of Hematology
American Association for the Advancement of Science
International Society for Experimental Hematology



Dr. LeBien has served on the Editorial Boards for:

  • Experimental Hematology, 2002 – 2006
  • Blood, 1988 – 1990
  • Leukemia, 1987 – 1996
  • Leukemia Research, 1985 – 1986
  • Journal of Immunology, 1984 – 1988


  • Burrows PD, LeBien TW, Zhang Z, Davis RS, Cooper MD. The development of human B lymphocytes. In: Molecular Biology of B cells; Honjo T, Alt FW, Neuberger M, eds. 2004. Elsevier Academic Press, pp141-154
  • Johnson SE, LeBien TW. Chapter 157: B-cell development. Fetal and Neonatal Physiology. 4th edition, Polin RA, Fox WW, Abman SH, eds. 2008

Peer-Reviewed Articles

  • Hermanson D, Addo SN, Bajer AA, Marchant JS, Das SG, Srinivasan B, Al-Mousa F, Michelangeli F, Thomas DD, Lebien TW, Xing C. Dual Mechanisms of sHA 14-1 in Inducing Cell Death through Endoplasmic Reticulum and Mitochondria. Mol Pharmacol. 2009 Jun 26.
  • LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008 Sep 1;112(5):1570-80.
  • Johnson SE, Shah N, Bajer AA, LeBien TW. IL-7 activates the PI3K/AKT pathway in normal human thymocytes but not normal human B-cell precursors. J Immunol. 2008 Jun 15;180(12):8109-17.
  • Johnson SE, Shah N, Panoskaltsis-Mortari A, and LeBien TW. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. 2005. J Immunol 175:7325-7331.

For a complete listing of Dr. LeBien's publications, please see the National Library of Medicine'sPubMed Search.